or
Bookmark and Share
Method of increasing feed utilization
   
Document Number
US Patent 4085224
Issued Date
April 18, 1978
Link
Inventors
Berg; David H. (Greenfield, IN)
Hoehn; Marvin M. (Indianapolis, IN)
Map
Abstract
Antibiotic A-28086 complex, comprising microbiologically active, structurally related factors A, B, and D, produced by submerged aerobic fermentation of Streptomyces aureofaciens NRRL 5758. Individual factors A, B, and D are separated and isolated by chromatography. The A-28086 antibiotics are antibacterial, antifungal, antiviral, anti-PPLO, anticoccidial, insecticidal and acaricidal agents and also increase feed-utilization efficiency in ruminants.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
2
Comments:
no comments yet
Owner
Eli Lilly and Company (Indianapolis, IN)
Published
April 18, 1978
Application Number
05/719,742
Filed
September 2, 1976
US Classification
514/455  
Int'l Classification
A23K   1/17   (20060101)   C07H   19/00   (20060101)   C07H   19/01   (20060101)  
Parent Case
CROSS-REFERENCE TO RELATED APPLICATION This is a division, of copending application Ser. No. 569,740 filed Apr. 21, 1975, which in turn is a continuation-in-part of application Ser. No. 477,954, filed June 10, 1974, now abandoned.
USPTO Field of Search
424/283  
Related Patents
4192887 - Ruminant coccidiostats - Owned by A. H. Robins Company, Incorporated (Richmond, VA)

Methods of preventing and controlling coccidiosis in ruminant animals and for improving rate of weight gain by oral administration of salinomycin or 4-methylsalinomycin are disclosed.

4291053 - Agent to be administered orally to domestic animals without cellulose digestion in the rumen - Owned by Hoechst Aktiengesellschaft (Frankfurt am Main,DE)

Agents containing Salinomycin for oral administration to domestic animals which do not digest cellulose in the rumen, particularly pigs, are disclosed, for instance for the prophylaxis or treatment of disease and/or for improvement of growth.

4260631 - Oral administration of Salinomycin to pigs - Owned by Hoechst Aktiengesellschaft (Frankfurt am Main,DE)

Agents containing Salinomycin for oral administration to domestic animals which do not digest cellulose in the rumen, particularly pigs, are disclosed, for instance for the prophylactic treatment of disease and/or for improvement of growth.

5364788 - Pure culture of Bacillus subtilis FERM BP-3418 - Owned by AHC Inc. (Maebashi,JP)

A bacterium belonging to Bacillus subtilis. The bacterium being identified as Bacillus subtilis FERM BP-3418. In addition the bacterium possesses the capability of decomposing aflatoxin. It is useful as an active ingredient in products such as a fungal growth inhibitor, fermentation promoter, and livestock fattening agent.

5667779 - Fungal inhibiting composition comprising Bacillus subtilis FERM BP-3418 - Owned by AHC Inc. (Maebashi,JP)

A bacterium belonging to Bacillus subtilis and having aflatoxin decomposing ability, as well as a fungal growth inhibitor, fermentation promoter and livestock fattening agent, all containing the bacterium as an active or effective ingredient. The Bacillus subtilis is strain FERM BP-3418. Also disclosed are methods for inhibiting or controlling a pathogenic fungus on a plant or animal.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us